FILE PHOTO: Jean-Paul Clozel, CEO of Swiss pharmaceutical company Idorsia, attends an interview with Reuters at the company’s headquarters in Allschwil near Basel, Switzerland May 15, 2018. Picture taken May 15, 2018. REUTERS/Arnd WiegmannZURICH (Reuters) – Idorsia’s insomnia drug was accepted for review by U.S. regulators, the Swiss drugmaker said on Wednesday, as founder Jean-Paul